Citigroup and RBC issued rating updates and price targets for Bio-Techne on June 6, 2026, which is listed on the Nasdaq stock exchange.
3 reports, 1 independent
Updated Aug 16
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup and RBC issued rating updates and price targets for Bio-Techne on June 6, 2026, which is listed on the Nasdaq stock exchange.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Bio-Techne
company
-
Citigroup
American investment bank and financial services corporation
Related events
- Citigroup and Royal Bank of Canada raised price targets and ratings for a company, with MarketBeat aggregating the financial data.
- Citigroup provided analyst ratings and reports for ServiceTitan stock, which trades on Nasdaq.
- Penguin Solutions, Inc. stock traded on Nasdaq, with Citigroup providing rating updates and legal filings made with the SEC.
- RBC and Citigroup boosted price objectives on Lockheed Martin shares, with MarketBeat aggregating the analyst ratings.
- Citigroup reiterated a market outperform rating for KB Home.